查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597045

綠色化學市場:綠色化學的措施，綠色化學·解決方案供應商的競爭情形，新的大趨勢，大型製藥公司的配合措施，企業簡介，主要的促進因素與阻礙因素

Green Chemistry Market: Focus on Green Chemistry Initiatives, Competitive Landscape of Green Chemistry Solution Providers, Emerging Mega Trends, Big Pharma Initiatives, Company Profiles and Key Drivers and Restraints
出版日期: | 出版商: Roots Analysis | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

製藥公司在其研究和製造過程中採用了綠色化學，在 60 多個已知用例中，綠色化學市場預計將穩步發展。

綠色化學涉及盡量減少或消除有害物質的化學產品和製程的設計、開發和實施。在製藥業，綠色化學對於促進環境永續性和提高化學合成效率至關重要。傳統的製藥生產是能源密集的，依賴不可再生資源，導致大量廢棄物的處理成本高。例如，全球活性藥物成分（API）的產量估計為每年 6,500 萬至 1 億公斤，產生約 100 億公斤廢棄物，加工成本約 200 億美元。

製藥業約佔全球二氧化碳排放量的 17%，其中近一半來自活性藥物成分及其原料的生產。隨著人們對環境的日益關注，迫切需要採用更環保的製造方法。因此，製藥公司正在將綠色化學原理融入其營運中，利用光化學、電化學和生物催化等多種技術。在製藥工業中，生物催化是綠色化學在化學合成上的重要應用。這種方法已展現出顯著的優勢，包括製造時間縮短 80%、產量提高、原材料成本降低 99% 以上，以及在純化過程中消除有機溶劑。

綠色化學為製藥業帶來了多種好處，包括減少對有害物質的依賴、降低成本和提高製程效率。因此，許多製藥公司越來越關注綠色化學，以確保永續的未來。尤其是阿斯特捷利康、巴斯夫和輝瑞等公司的目標是到 2040 年或 2050 年實現整個供應鏈的淨零排放。這些努力符合全球監管標準，並滿足消費者對環保產品日益增長的需求。

隨著企業增加對綠色化學和永續技術的投資，綠色化學市場預計將顯著成長，為藥物開發和製造領域更永續和負責任的未來鋪平道路。

本報告提供全球綠色化學市場相關調查，提供市場概要，以及綠色化學·解決方案供應商的競爭情形，新的大趨勢，大型製藥公司的配合措施，企業簡介等資訊。

目錄

章節I:報告概要

第1章 範圍和目的

第2章 調查手法

章節II:定性性的洞察

第3章 摘要整理

第4章 簡介

章節III:市場概要

第5章 市場形勢:製藥產業的綠色化學的配合措施

第6章 市場形勢:綠色化學·解決方案供應商

章節IV:企業簡介和案例研究

第7章 企業簡介

  • 章概要
  • Amgen
  • AstraZeneca
  • Bristol Myers Squibb
  • Codexis
  • Johnson &Johnson
  • Merck
  • Merck KGaA
  • Pfizer

第8章 案例研究:大型製藥公司的配合措施

第5章 市場趨勢

第9章 綠色化學市場:進行中的兆趨勢概要

第10章 對市場的影響分析:促進因素，阻礙因素，機會，課題

第5章 附錄

第11章 表格形式的資料

第12章 企業·團體一覽

Product Code: RA100565

With more than 60 known use cases in which pharmaceutical companies have employed green chemistry in their research / manufacturing processes, the green chemistry market is anticipated to evolve at a steady pace.

Green chemistry involves the design, development and implementation of chemical products and processes that minimize or eliminate hazardous substances. In the pharmaceutical industry, green chemistry is vital for promoting environmental sustainability and improving the efficiency of chemical synthesis. Traditional drug manufacturing is energy-intensive and dependent on non-renewable resources, leading to significant waste generation and costly disposal. For example, global production of active pharmaceutical ingredients (APIs) is estimated to be 65 million to 100 million kilograms annually, generating approximately 10 billion kilograms of waste, with disposal costs around $20 billion.

The pharmaceutical industry is responsible for approximately 17% of global carbon emissions, with nearly half of this footprint stemming from the manufacturing of APIs and their raw materials. With increasing environmental concerns, there is an urgent need for industry to adopt greener production methods. Consequently, pharmaceutical companies are integrating green chemistry principles into their operations, utilizing various techniques such as photochemistry, electrochemistry, and biocatalysis. In the pharmaceutical industry, biocatalysis presents a significant application of green chemistry in chemical synthesis. This approach has demonstrated significant advantages, including reduction in manufacturing time by 80%, increase in production yield, decrease in the cost of starting materials by more than 99%, and elimination of the use of organic solvents during purification processes.

Green chemistry provides various benefits to the pharmaceutical industry, including reduced reliance on toxic substances, cost savings, and enhanced process efficiency. Thus, many pharmaceutical companies are increasingly focusing on green chemistry to ensure a sustainable future. Notably, firms such as AstraZeneca, BASF, and Pfizer are aiming for net-zero emissions across their supply chains by 2040 or 2050. These efforts align with global regulatory standards and respond to rising consumer demand for eco-friendly products.

As companies increasingly invest in green chemistry and sustainable technologies, the green chemistry market is expected to experience substantial growth, paving the way for a more sustainable and responsible future in drug development and manufacturing.

Research Coverage:

The report on green chemistry market covers the following elements:

  • A project background providing an introduction to the context of the green chemistry market report and outlining various project objectives.
  • An overview of the systematic research methodology employed to study the green chemistry industry, providing information on various assumptions, methodologies, and quality control measures used to ensure the accuracy and reliability of our findings.
  • An infographic executive summary presenting key insights gathered during our research, providing a high-level perspective on the current state of green chemistry initiatives and green chemistry solution providers.
  • A general overview of green chemistry, covering the 12 principles of green chemistry and prominent types of green chemistry methods. It also discusses various applications of green chemistry and addresses the challenges associated with its implementation.
  • A comprehensive assessment of green chemistry initiatives within the pharma industry, based on several relevant parameters, such as the type of green chemistry method involved (biocatalysis, electrochemistry, photochemistry and others), purpose of initiative (research and manufacturing), therapeutic area of drug synthesized (cardiovascular disorders, infectious diseases, metabolic disorders, neurological disorders, oncological disorders, respiratory disorders and other disorders) and impact of initiative (energy efficient processes, improvement in yield, reduction in carbon footprint, reduction in manufacturing time, reduction in metal consumption, reduction in solvent-use, reduction in waste and others). Further, the report also provides information on the green chemistry initiatives stakeholders, along with analysis on various parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country).
  • An evaluation of the green chemistry solution providers, based on various relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country), type of solution offered (product, platform and service), type of green chemistry method involved (biocatalysis, electrochemistry and photochemistry), pharmaceutical application (research, manufacturing and other applications), and type of service offered (research, product / process development, manufacturing, scale-up and other services).
  • Elaborate profiles of key companies in the green chemistry market. Each profile includes a brief overview of the company (year of establishment, location of headquarters, number of employees, management team and business segments), information on their green chemistry initiatives, recent developments and an informed future outlook.
  • A comprehensive case study on big pharma initiatives that examine the impact of green chemistry practices on the pharmaceutical industry.
  • A detailed assessment of various ongoing megatrends in the green chemistry industry, including rising demand for sustainable drug manufacturing, technological advancements in green chemistry practices, integration of continuous flow manufacturing with green chemistry practices, convergence of AI, data science with green chemistry applications, development of sustainability metrices, and many more.
  • A detailed analysis identifying factors that influence the growth of green chemistry market. It includes insights into key drivers, potential restraints, emerging opportunities, and existing challenges in this domain.

Key Benefits of Buying this Report

  • The report provides valuable insights into key green chemistry solution providers that are shaping the market landscape and driving sustainable practices in the industry.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with an overall outlook of the green chemistry market, featuring essential information on significant market drivers, barriers, opportunities, and challenges.

Example Companies Profiled

  • Amgen
  • AstraZeneca
  • Bristol Myers Squibb
  • Codexis
  • Johnson & Johnson
  • Merck
  • Merck KGaA
  • Pfizer

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. SCOPE AND OBJECTIVES

  • 1.1. Context
  • 1.2. Project Objectives

2. RESEARCH METHODOLOGY

  • 2.1. Project Methodology
  • 2.2. Robust Quality Control Framework

SECTION II: QUALITATIVE INSIGHTS

3. EXECUTIVE SUMMARY

4. INTRODUCTION

  • 4.1. An Overview of Green Chemistry
  • 4.2. 12 Principles of Green Chemistry
  • 4.3. Types of Green Chemistry Methods
  • 4.4. Applications of Green Chemistry
  • 4.5. Key Challenges in Green Chemistry Domain

SECTION III: MARKET OVERVIEW

5. MARKET LANDSCAPE: GREEN CHEMISTRY INITIATIVES IN PHARMA INDUSTRY

  • 5.1. Methodology and Key Parameters
  • 5.2. Green Chemistry Initiatives: Overall Market Landscape
    • 5.2.1. Analysis by Type of Green Chemistry Method Involved
    • 5.2.2. Analysis by Purpose of Initiative
    • 5.2.3. Analysis by Therapeutic Area of Drug Synthesized
    • 5.2.4. Analysis by Impact of Initiative
  • 5.3. Green Chemistry Initiatives Stakeholders: Overall Market Landscape
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Location of Headquarters

6. MARKET LANDSCAPE: GREEN CHEMISTRY SOLUTION PROVIDERS

  • 6.1. Methodology and Key Parameters
  • 6.2. Green Chemistry Solution Providers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters
    • 6.2.4. Analysis by Type of Solution Offered
    • 6.2.5. Analysis by Type of Green Chemistry Method Involved
    • 6.2.6. Analysis by Pharmaceutical Application
    • 6.2.7. Analysis by Type of Service Offered

SECTION IV: COMPANY PROFILES AND CASE STUDY

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Amgen
    • 7.2.1. Company Overview
    • 7.2.2. Company Mission
    • 7.2.3. Company Footprint
    • 7.2.4. Management Team
    • 7.2.5. Contact Details
    • 7.2.6. Green Chemistry Initiatives
    • 7.2.7. Recent Developments and Future Outlook
  • 7.3. AstraZeneca
    • 7.3.1. Company Overview
    • 7.3.2. Company Mission
    • 7.3.3. Company Footprint
    • 7.3.4. Management Team
    • 7.3.5. Contact Details
    • 7.3.6. Green Chemistry Initiatives
    • 7.3.7. Recent Developments and Future Outlook
  • 7.4. Bristol Myers Squibb
    • 7.4.1. Company Overview
    • 7.4.2. Company Mission
    • 7.4.3. Company Footprint
    • 7.4.4. Management Team
    • 7.4.5. Contact Details
    • 7.4.6. Green Chemistry Initiatives
    • 7.4.7. Recent Developments and Future Outlook
  • 7.5. Codexis
    • 7.5.1. Company Overview
    • 7.5.2. Company Mission
    • 7.5.3. Company Footprint
    • 7.5.4. Management Team
    • 7.5.5. Contact Details
    • 7.5.6. Green Chemistry Initiatives
    • 7.5.7. Recent Developments and Future Outlook
  • 7.6. Johnson & Johnson
    • 7.6.1. Company Overview
    • 7.6.2. Company Mission
    • 7.6.3. Company Footprint
    • 7.6.4. Management Team
    • 7.6.5. Contact Details
    • 7.6.6. Green Chemistry Initiatives
  • 7.7. Merck
    • 7.7.1. Company Overview
    • 7.7.2. Company Mission
    • 7.7.3. Company Footprint
    • 7.7.4. Management Team
    • 7.7.5. Contact Details
    • 7.7.6. Green Chemistry Initiatives
    • 7.7.7. Recent Developments and Future Outlook
  • 7.8. Merck KGaA
    • 7.8.1. Company Overview
    • 7.8.2. Company Mission
    • 7.8.3. Company Footprint
    • 7.8.4. Management Team
    • 7.8.5. Contact Details
    • 7.8.6. Green Chemistry Initiatives
    • 7.8.7. Recent Developments and Future Outlook
  • 7.9. Pfizer
    • 7.9.1. Company Overview
    • 7.9.2. Company Mission
    • 7.9.3. Company Footprint
    • 7.9.4. Management Team
    • 7.9.5. Contact Details
    • 7.9.6. Green Chemistry Initiatives
    • 7.9.7. Recent Developments and Future Outlook

8. CASE STUDY: BIG PHARMA INITIATIVES

  • 8.1. Methodology and Key Parameters
  • 8.2. Green Chemistry: Big Pharma Initiatives
    • 8.2.1. Johnson & Johnson
    • 8.2.2. Roche
    • 8.2.3. Merck
    • 8.2.4. Pfizer
    • 8.2.5. AbbVie
    • 8.2.6. AstraZeneca
    • 8.2.7. Novartis
    • 8.2.8. Bristol Myers Squibb
    • 8.2.9. GlaxoSmithKline

SECTION V: MARKET TRENDS

9. GREEN CHEMISTRY MARKET: OVERVIEW OF ONGOING MEGA TRENDS

  • 9.1. Megatrends in the Green Chemistry Market
    • 9.1.1. Shift Towards Sustainable Drug Manufacturing
    • 9.1.2. Technological Advancements in Green Chemistry
    • 9.1.3. Integration of Continuous Flow Manufacturing in Green Chemistry
    • 9.1.4. Emphasis on Waste Valorization and Circular Chemistry
    • 9.1.5. Convergence of AI, Data Science and Green Chemistry
    • 9.1.6. Establishing Sustainability Metrices
    • 9.1.7. Increasing Adoption by Big-Pharma Companies
    • 9.1.8. Growing Regulatory Pressures

10. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 10.1. Market Drivers
  • 10.2. Market Restraints
  • 10.3. Market Opportunities
  • 10.4. Market Challenges

SECTION V: APPENDIX

11. TABULATED DATA

12. LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 5.1 List of Green Chemistry Initiatives: Information on Type of Green Chemistry Method Involved, Purpose of Initiative, Impact of Initiative, Type of Product Targeted, and Therapeutic Area of Drug Synthesized
  • Table 5.2 List of Green Chemistry Initiatives Stakeholders
  • Table 6.1 List of Key Companies Offering Green Chemistry Solutions
  • Table 6.2 List of Companies Offering Green Chemistry Products and Platforms: Information on Type of Solution Offered, Type of Green Chemistry Method Involved and Pharmaceutical Application
  • Table 6.3 List of Companies Offering Green Chemistry Services: Information on Type of Type of Green Chemistry Method Involved and Type of Service Offered
  • Table 7.1 Amgen: Green Chemistry Initiatives
  • Table 7.2 AstraZeneca: Green Chemistry Initiatives
  • Table 7.3 Bristol Myers Squibb: Green Chemistry Initiatives
  • Table 7.4 Codexis: Green Chemistry Initiatives
  • Table 7.5 Johnson & Johnson: Green Chemistry Initiatives
  • Table 7.6 Merck: Green Chemistry Initiatives
  • Table 7.7 Merck KGaA: Green Chemistry Initiatives
  • Table 7.8 Pfizer: Green Chemistry Initiatives
  • Table 11.1 Green Chemistry Initiatives: Distribution by Type of Green Chemistry Method Involved
  • Table 11.2 Green Chemistry Initiatives: Distribution by Purpose of Initiative
  • Table 11.3 Green Chemistry Initiatives: Distribution by Therapeutic Area of API / Drug Synthesized
  • Table 11.4 Green Chemistry Initiatives: Distribution by Impact of Initiative
  • Table 11.5 Green Chemistry Initiatives Stakeholders: Distribution by Year of Establishment
  • Table 11.6 Green Chemistry Initiatives Stakeholders: Distribution by Company Size
  • Table 11.7 Green Chemistry Initiatives Stakeholders: Distribution by Location of Headquarters
  • Table 11.8 Green Chemistry Solution Providers: Distribution by Year of Establishment
  • Table 11.9 Green Chemistry Solution Providers: Distribution by Company Size
  • Table 11.10 Green Chemistry Solution Providers: Distribution by Location of Headquarters
  • Table 11.11 Green Chemistry Solution Providers: Distribution by Type of Solution Offered
  • Table 11.12 Green Chemistry Solution Providers: Distribution by Type of Green Chemistry Method Involved
  • Table 11.13 Green Chemistry Solution Providers: Distribution by Pharmaceutical Application
  • Table 11.14 Green Chemistry Solution Providers: Distribution by Type of Service Offered

List of Figures

  • Figure 1.1 Research Methodology: Project Methodology
  • Figure 1.2 Research Methodology: Robust Quality Control
  • Figure 3.1 Executive Summary: Market Landscape of Green Chemistry Initiatives in Pharma Industry
  • Figure 3.2 Executive Summary: Market Landscape of Green Chemistry Solution Providers
  • Figure 4.1 12 Principles of Green Chemistry
  • Figure 5.1 Green Chemistry Initiatives: Distribution by Type of Green Chemistry Method Involved
  • Figure 5.2 Green Chemistry Initiatives: Distribution by Purpose of Initiative
  • Figure 5.3 Green Chemistry Initiatives: Distribution by Therapeutic Area of API / Drug Synthesized
  • Figure 5.4 Green Chemistry Initiatives: Distribution by Impact of Initiative
  • Figure 5.5 Green Chemistry Initiatives Stakeholders: Distribution by Year of Establishment
  • Figure 5.6 Green Chemistry Initiatives Stakeholders: Distribution by Company Size
  • Figure 5.7 Green Chemistry Initiatives Stakeholders: Distribution by Location of Headquarters
  • Figure 6.1 Green Chemistry Solution Providers: Distribution by Year of Establishment
  • Figure 6.2 Green Chemistry Solution Providers: Distribution by Company Size
  • Figure 6.3 Green Chemistry Solution Providers: Distribution by Location of Headquarters
  • Figure 6.4 Green Chemistry Solution Providers: Distribution by Type of Solution Offered
  • Figure 6.5 Green Chemistry Solution Providers: Distribution by Type of Green Chemistry Method Involved
  • Figure 6.6 Green Chemistry Solution Providers: Distribution by Pharmaceutical Application
  • Figure 6.7 Green Chemistry Solution Providers: Distribution by Type of Service Offered
  • Figure 9.1 Schematic Representation of Ongoing Megatrends